12:00 AM
Mar 30, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Dengue treatment: Phase I start

Novartis plans to begin clinical testing of a new compound to treat Dengue fever in 2011 after the company discontinued its...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >